The in vitro experiments provide evidence that 17β-estradiol stimulates CB1 expression via the activation of the estrogen receptors ERα and ERβ in the primary tumor CRC cell lines DLD-1 and HT-29 and the lymph node metastatic cell line SW620. Here, ESR1 is linked to colorectal carcinoma.